These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 21978982

  • 81.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 82. Valproate-induced hyperammonemic encephalopathy.
    Segura-Bruna N, Rodriguez-Campello A, Puente V, Roquer J.
    Acta Neurol Scand; 2006 Jul; 114(1):1-7. PubMed ID: 16774619
    [Abstract] [Full Text] [Related]

  • 83. 4217C>A polymorphism in carbamoyl-phosphate synthase 1 gene may not associate with hyperammonemia development during valproic acid-based therapy.
    Inoue K, Suzuki E, Takahashi T, Yamamoto Y, Yazawa R, Takahashi Y, Imai K, Miyakawa K, Inoue Y, Tsuji D, Hayashi H, Itoh K.
    Epilepsy Res; 2014 Aug; 108(6):1046-51. PubMed ID: 24888247
    [Abstract] [Full Text] [Related]

  • 84.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 85. [Successful balloon-occluded retrograde transvenous obliteration (B-RTO) in a case of symptomatic epilepsy with hepatic encephalopathy due to non-cirrhotic porto-systemic shunt].
    Shibata A, Hayashi S, Noguchi M.
    Rinsho Shinkeigaku; 2005 May; 45(5):341-5. PubMed ID: 15960169
    [Abstract] [Full Text] [Related]

  • 86. Hyperammonemia and coma without hepatic dysfunction induced by valproate therapy.
    Barrueto F, Hack JB.
    Acad Emerg Med; 2001 Oct; 8(10):999-1001. PubMed ID: 11581089
    [Abstract] [Full Text] [Related]

  • 87.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 88. Hallucinations after withdrawal of valproic acid.
    de Laat SA, Hillegers MH, Jansen FE, Braun KP, de Graeff-Meeder ER.
    Pediatrics; 2012 Jul; 130(1):e236-8. PubMed ID: 22689876
    [Abstract] [Full Text] [Related]

  • 89. Hyperammonemia following intravenous valproate loading.
    DeWolfe JL, Knowlton RC, Beasley MT, Cofield S, Faught E, Limdi NA.
    Epilepsy Res; 2009 Jul; 85(1):65-71. PubMed ID: 19299111
    [Abstract] [Full Text] [Related]

  • 90.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 91.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 92. Serum biotinidase activity in children treated with valproic acid and carbamazepine.
    Castro-Gago M, Gómez-Lado C, Eirís-Puñal J, Díaz-Mayo I, Castiñeiras-Ramos DE.
    J Child Neurol; 2010 Jan; 25(1):32-5. PubMed ID: 19458381
    [Abstract] [Full Text] [Related]

  • 93.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 94.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 95.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 96. Valproic acid-induced encephalopathy in very long course treated patients.
    Rousseau MC, Montana M, Villano P, Catala A, Blaya J, Valkov M, Allouard Y, Bugni E.
    Brain Inj; 2009 Nov; 23(12):981-4. PubMed ID: 19831495
    [Abstract] [Full Text] [Related]

  • 97. [Is treatment with a daily dose of Depakine Crono safe?].
    Martínez-Salio A, Porta-Etessam J, Berbel A, Manzanares-Secades C, Alvarez-Tejerina J, De La Peña P.
    Rev Neurol; 2009 Nov; 34(11):1095-6. PubMed ID: 12134312
    [No Abstract] [Full Text] [Related]

  • 98.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 99.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 100.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.